Kimberly Vanover Net Worth & Insider Trades

Kimberly Vanover - SVP, Intra-Cellular Therapies, Inc

As of January 8, 2019

What is Kimberly Vanover's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's SVP, Kimberly Vanover, is estimated to be about $2.48M . Kimberly Vanover owns about 27,068 units of Intra-Cellular Therapies, Inc common stock. In the last 5 years at Intra-Cellular Therapies, Inc, Kimberly Vanover has sold an estimated value of $360.74K worth.

What is Kimberly Vanover's Past Insider Trading?

Kimberly Vanover's largest purchase order was 18,750 units , worth over $27.43K on December 19, 2016. Kimberly Vanover's largest sale order was 9,375 units , worth over $142.77K on December 19, 2016. In total, Kimberly Vanover has made about 10 transactions over 5 years of their time at Intra-Cellular Therapies, Inc. Kimberly Vanover usually trades in January, with the busiest year in 2017, 2016, 2018 and 2019. The most recent transaction was a sale order of 10,156 units , worth over $116.98K on January 8, 2019.

Kimberly Vanover

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kimberly Vanover's' Mailing Address?

  • Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on December 2, 2022 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $105.92M and bought an estimated value of $63.6M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1